Stockreport

RXi Pharmaceuticals to Present New Data from its Immuno-Oncology Program Using sd-rxRNA Therapeutic Compounds Targeting Intracellular Checkpoint Cbl-b in NK Cells at the 16th Annual Discov...

RXI PHARMACEUTICALS CORP  (RXII) 
Last rxi pharmaceuticals corp earnings: 11/14 07:10 am Check Earnings Report
US:NASDAQ Investor Relations: investors.rxipharma.com
PDF MARLBOROUGH, Mass., Sept. 26, 2018 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII) a biotechnology company developing the next generation of immuno-oncolo [Read more]